136 related articles for article (PubMed ID: 24839818)
1. Detection of circulating methylated opioid binding protein/cell adhesion molecule-like gene as a biomarker for ovarian carcinoma.
Zhou F; Ma M; Tao G; Chen X; Xie W; Wang Y; Cao X
Clin Lab; 2014; 60(5):759-65. PubMed ID: 24839818
[TBL] [Abstract][Full Text] [Related]
2. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
[TBL] [Abstract][Full Text] [Related]
3. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
[TBL] [Abstract][Full Text] [Related]
4. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
Zhou F; Cao X; Liu M; Wang Y; Tao G
Clin Lab; 2011; 57(5-6):421-4. PubMed ID: 21755835
[TBL] [Abstract][Full Text] [Related]
5. [Detection of circulating hypermethylated tumor-specific RASSF1A DNA in ovarian cancer patients].
Ma L; Liu FR; Zhang SL
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):785-7. PubMed ID: 16545186
[TBL] [Abstract][Full Text] [Related]
6. Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma.
Chen H; Ye F; Zhang J; Lu W; Cheng Q; Xie X
Eur J Gynaecol Oncol; 2007; 28(6):464-7. PubMed ID: 18179137
[TBL] [Abstract][Full Text] [Related]
7. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].
Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898
[TBL] [Abstract][Full Text] [Related]
8. Application of multiplex nested methylated specific PCR in early diagnosis of epithelial ovarian cancer.
Wang B; Yu L; Yang GZ; Luo X; Huang L
Asian Pac J Cancer Prev; 2015; 16(7):3003-7. PubMed ID: 25854397
[TBL] [Abstract][Full Text] [Related]
9. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
Mei FC; Young TW; Liu J; Cheng X
FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
[TBL] [Abstract][Full Text] [Related]
11. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
[TBL] [Abstract][Full Text] [Related]
12. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.
Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J
Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.
Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T
Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468
[TBL] [Abstract][Full Text] [Related]
14. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
Lian B; Li H; Liu Y; Chai D; Gao Y; Zhang Y; Zhou J; Li J
Breast Cancer; 2021 Mar; 28(2):448-458. PubMed ID: 33108608
[TBL] [Abstract][Full Text] [Related]
15. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
Ma L; Zhang JH; Liu FR; Zhang X
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
Terp SK; Stoico MP; Dybkær K; Pedersen IS
Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
[TBL] [Abstract][Full Text] [Related]
17. Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.
Wang B; Yu L; Luo X; Huang L; Li QS; Shao XS; Liu Y; Fan Y; Yang GZ
Oncol Lett; 2017 Jul; 14(1):217-223. PubMed ID: 28693156
[TBL] [Abstract][Full Text] [Related]
18. Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.
Zhang N; Xu J; Wang Y; Heng X; Yang L; Xing X
Oncol Lett; 2018 Jun; 15(6):9973-9977. PubMed ID: 29805691
[TBL] [Abstract][Full Text] [Related]
19. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
Cui Y; Ying Y; van Hasselt A; Ng KM; Yu J; Zhang Q; Jin J; Liu D; Rhim JS; Rha SY; Loyo M; Chan AT; Srivastava G; Tsao GS; Sellar GC; Sung JJ; Sidransky D; Tao Q
PLoS One; 2008 Aug; 3(8):e2990. PubMed ID: 18714356
[TBL] [Abstract][Full Text] [Related]
20. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.
McKie AB; Vaughan S; Zanini E; Okon IS; Louis L; de Sousa C; Greene MI; Wang Q; Agarwal R; Shaposhnikov D; Wong JL; Gungor H; Janczar S; El-Bahrawy M; Lam EW; Chayen NE; Gabra H
Cancer Discov; 2012 Feb; 2(2):156-71. PubMed ID: 22585860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
